Treventis Corporation
Records under this name other than the patents Treventis Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Showing 1 to 4 of 4 · Back to Treventis Corporation
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,795,630 | Butyrylcholinesterase Ligands as Diagnostic Tools and Treatment for Deseases of the Nervous System Lapsed on the fee record Ended Aug 5, 2026 · High confidence | Lapsed on the fee record | Ended Aug 5, 2026 | High confidence |
| US 6,436,972 | Pyridones and their use as modulators of serine hydrolase enzymes Term ended Term ended Apr 10, 2020 · USPTO record | Term ended | Term ended Apr 10, 2020 | USPTO record |
| US 6,544,986 | Pyridones and their use as modulators of serine hydrolase enzymes Term ended Term ended Apr 10, 2020 · USPTO record | Term ended | Term ended Apr 10, 2020 | USPTO record |
| US 8,362,066 | Compounds and methods for treating protein folding disorders Lapsed on the fee record Ended Jan 29, 2017 · USPTO record | Lapsed on the fee record | Ended Jan 29, 2017 | USPTO record |